A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
Clinical trial NCT00866736 · COMPLETED
Trial details
- NCT number
- NCT00866736
- Sponsor
- Kanto CML Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-06-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.